📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Adolor

1.1 - Company Overview

Adolor Logo

Adolor

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical discovery, development and commercialization focused on prescription pain and pain-management products. Offers ENTEREG (alvimopan), an FDA-approved product indicated to accelerate upper and lower gastrointestinal recovery.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Adolor

Neurimmune Logo

Neurimmune

HQ: Switzerland Website
  • Description: Provider of immunotherapeutics using a Reverse Translational Medicine (RTM) platform to generate recombinant human-derived monoclonal antibodies. Pipeline includes NI101SQ (subcutaneous aducanumab) for Alzheimer’s, AP-101 for ALS, ALXN2220 for ATTR-CM, NI203 for type-2 diabetes, and human anti-SARS-CoV-2 antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neurimmune company profile →
NeurogesX Logo

NeurogesX

HQ: United States Website
  • Description: Provider of therapies for chronic peripheral neuropathic pain through development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeurogesX company profile →
Minerva Neurosciences Logo

Minerva Neurosciences

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical product candidates for central nervous system diseases, including roluperidone (MIN-101) for negative symptoms of schizophrenia targeting serotonin, sigma, and alpha-adrenergic receptors, and MIN-301, a recombinant neuregulin-1β1 in preclinical development for Parkinson’s disease aimed at restoring brain tissue damage and improving motor function.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Minerva Neurosciences company profile →
BioDelivery Sciences International Logo

BioDelivery Sciences International

HQ: United States Website
  • Description: Provider of pharmaceutical solutions focused on pain management and addiction medicine, leveraging proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology to develop and commercialize new applications of proven therapies independently or through partnerships.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioDelivery Sciences International company profile →
Mindset Pharma Logo

Mindset Pharma

HQ: Canada Website
  • Description: Provider of drug discovery and development focused on creating optimized, patentable next-generation psilocybin-inspired medicines and novel psychedelic compounds to treat neurological and psychiatric disorders, developing serotonin 5-HT2A agonists for conditions such as treatment-resistant depression and PTSD.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mindset Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Adolor

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Adolor

2.2 - Growth funds investing in similar companies to Adolor

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Adolor

4.2 - Public trading comparable groups for Adolor

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Adolor

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Adolor

What does Adolor do?

Adolor is a provider of biopharmaceutical discovery, development and commercialization focused on prescription pain and pain-management products. Offers ENTEREG (alvimopan), an FDA-approved product indicated to accelerate upper and lower gastrointestinal recovery.

Who are Adolor's competitors?

Adolor's competitors and similar companies include Neurimmune, NeurogesX, Minerva Neurosciences, BioDelivery Sciences International, and Mindset Pharma.

Where is Adolor headquartered?

Adolor is headquartered in United States.

How many employees does Adolor have?

Adolor has 1,000 employees 🔒.

When was Adolor founded?

Adolor was founded in 2010 🔒.

What sector and industry vertical is Adolor in?

Adolor is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adolor

Who are the top strategic acquirers in Adolor's sector and industry

Top strategic M&A buyers and acquirers in Adolor's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adolor?

Top strategic M&A buyers groups and sectors for Adolor include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adolor's sector and industry vertical

Which are the top PE firms investing in Adolor's sector and industry vertical?

Top PE firms investing in Adolor's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adolor's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adolor's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adolor's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adolor include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adolor's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adolor?

The key public trading comparables and valuation benchmarks for Adolor include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adolor for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adolor with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adolor's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adolor with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adolor's' sector and industry vertical?

Access recent funding rounds and capital raises in Adolor's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Adolor